The C.L.E.A.R. approach of protective hemodynamics in critically ill patients is a step forward in embracing complexity, moving beyond simple pressure targets. 🩺🔄 It’s time to rethink how we manage cardiovascular stability in critical care. Read our full review for more

Dzisiaj prof. Roman Jaeschke otrzymał tytuł doktora honoris causa Uniwersytetu Jagiellońskiego - najważniejsze wyróżnienie uniwersyteckie. Piękna i podniosła uroczystość! To wielkie szczęście żeby na swojej ścieżce życiowej natrafić na prawdziwego Mentora. Ja takie szczęście

Evidence on blood pressure targets in critically ill patients shows that Mean Arterial Pressure is not always equal to end-organ perfusion. 🩸 The future? Customize blood pressure targets. 🔄💡 All discussed in our review on Protective Haemodynamics! jcvaonline.com/article/S1053-…

This is terrible esicm.org/obituary-lucia…

Br. Guy Consolmagno, SJ, director of the director of Vatican Observatory: “When we show the universe is rational and beautiful, we are telling you something about the personality of the creator.” thetimes.com/comment/the-ti…

Wszystko, co mówi poseł Romana Fritz z mównicy sejmowej jest kłamstwem. Najwyraźniej nie przeczytał wytycznych o których wspomina (przytaczane przykłady są nieprawdziwe), nie ma pojęcia jak wygląda proces umierania, nie wie czym jest terapia daremna. Powtarza określenie eutanazja

Truly remarkable discoveries with far greater significance than you might expect!

Could intravenous lidocaine enhance sedation for colonoscopy? Our SRMA shows it reduces propofol use, shortens awakening time, alleviates post-procedural pain, and improves patient satisfaction. 𝘈𝘯𝘢𝘦𝘴𝘵𝘩𝘦𝘴𝘪𝘢 👉 pubmed.ncbi.nlm.nih.gov/40102176/ #MedTwitter #GITwitter

Christ is risen! Life is stronger than death. Love is stronger than hate. Hope is stronger than despair. And nothing is impossible with God! Happy Easter! Image Kelly Latimore Icons

A new addition to the ANDROMEDA-SHOCK family: PEGASUS! Providing an epidemiological perspective to the RR between pulse pressure and stroke volume! Fundamental study after A2! Cross-talk now between Physiology and Epidemiology!! NCT 06737614

Less is more wins again. RCT of high MAP target in older adults w/sepsis, stopped early for harm, 39% mortality MAP 80-85 vs. 29% mortality MAP 65-70 link.springer.com/article/10.100…. Recall also that the 65 Trial hinted that MAP60 may be better than 65. How low can we go?

We were the first to highlight that choosing a high target increases the risk of adverse events. journals.lww.com/ccmjournal/abs… Now, another piece of evidence—interrupted at interim analysis due to harm in the high-target group. Are we ready for the era of Protective Hemodynamics?

ANDROMEDA-PEGASUS on fire! Less than 2 months since the study started and steady increase in recruitment every day! ANDROMEDA-SHOCK Philippe Rola ESICM Fernando Ramasco Rueda Dr. Miguel Ibarra-Estrada Ross Prager Zbigniew Putowski

Rationale for the ANDROMEDA-PEGASUS study just out in Critical Care !!! ANDROMEDA-SHOCK Eduardo Kattan !!! ccforum.biomedcentral.com/articles/10.11…

Wielki sukces Wojciech Szczeklik! Prestiżowa konferencja, wyjątkowa sesja i największe polskie badanie! Gratulacje!

Today I had the privilege to present results of PREVENT-MINS trial at the #ESCCongress2025 European Society of Cardiology in Barcelona (Hot-Line session) on behalf of trial investigators. The study was published simultaneously in Circulation Circulation - here are some main insights of the study 🧵👇